Department of Microbiology and Immunology, Stanford University, Stanford, California.
Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Cancer Immunol Res. 2017 Sep;5(9):744-754. doi: 10.1158/2326-6066.CIR-17-0012. Epub 2017 Aug 2.
Multiple myeloma is characterized by the clonal expansion of malignant plasma cells in the bone marrow. But the phenotypic diversity and the contribution of less predominant B-lineage clones to the biology of this disease have been controversial. Here, we asked whether cells bearing the dominant multiple myeloma immunoglobulin rearrangement occupy phenotypic compartments other than that of plasma cells. To accomplish this, we combined 13-parameter FACS index sorting and t-Stochastic Neighbor Embedding (t-SNE) visualization with high-throughput single-cell immunoglobulin sequencing to track selected B-lineage clones across different stages of human B-cell development. As expected, the predominant clones preferentially mapped to aberrant plasma cell compartments, albeit phenotypically altered from wild type. Interestingly, up to 1.2% of cells of the predominant clones colocalized with B-lineage cells of a normal phenotype. In addition, minor clones with distinct immunoglobulin sequences were detected in up to 9% of sequenced cells, but only 2 out of 12 of these clones showed aberrant immune phenotypes. The majority of these minor clones showed intraclonal silent nucleotide differences within the CDR3s and varying frequencies of somatic mutations in the immunoglobulin genes. Therefore, the phenotypic range of multiple myeloma cells in the bone marrow is not confined to aberrant-phenotype plasma cells but extends to low frequencies of normal-phenotype B cells, in line with the recently reported success of B cell-targeting cellular therapies in some patients. The majority of minor clones result from parallel nonmalignant expansion. .
多发性骨髓瘤的特征是骨髓中恶性浆细胞的克隆性扩张。但是,表型多样性和较少占主导地位的 B 细胞系克隆对该疾病生物学的贡献一直存在争议。在这里,我们想知道是否携带显性多发性骨髓瘤免疫球蛋白重排的细胞占据了除浆细胞以外的表型区室。为了实现这一目标,我们将 13 个参数的 FACS 指数分选与高通量单细胞免疫球蛋白测序相结合,以跟踪选定的 B 细胞系克隆在人类 B 细胞发育的不同阶段。不出所料,优势克隆优先映射到异常浆细胞区室,尽管表型上与野生型不同。有趣的是,高达 1.2%的优势克隆细胞与正常表型的 B 细胞系细胞共定位。此外,多达 9%的测序细胞中检测到具有不同免疫球蛋白序列的次要克隆,但在这 12 个克隆中只有 2 个表现出异常免疫表型。这些次要克隆中的大多数在 CDR3 内表现出克隆内沉默核苷酸差异,并且在免疫球蛋白基因中具有不同的体细胞突变频率。因此,骨髓中多发性骨髓瘤细胞的表型范围不仅局限于异常表型的浆细胞,而且还扩展到正常表型 B 细胞的低频率,与最近报道的某些患者中 B 细胞靶向细胞疗法的成功一致。大多数次要克隆是由平行的非恶性扩张引起的。